During the past decade, SC3 Research Group, Inc conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 6 clinical trials were completed, i.e. on average, 20.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 5 clinical trials were completed. i.e. 31.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SC3 Research Group, Inc" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Enterin Inc." with 2 trials sponsored, "Impax Laboratories, LLC" with 2 trials sponsored and "Intec Pharma Ltd." with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SC3 Research Group, Inc" #1 collaborator was "Acorda Therapeutics" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Denali Therapeutics Inc." with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "SC3 Research Group, Inc" are "Parkinson Disease" (7 trials), "Multiple Sclerosis" (4 trials), "Parkinson's Disease" (4 trials), "Constipation" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "SC3 Research Group, Inc" in a lesser frequency.

Most popular intervention types in "SC3 Research Group, Inc" are "Drug" (28 trials), "Other" (5 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Ocrelizumab" (3 trials), "Accordion Pill™ Carbidopa/Levodopa" (2 trials), "Active Investigational Treatment ENT-01" (2 trials) and "Antihistamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "SC3 Research Group, Inc" are 29 trials for "All" genders.

Currently, there are NaN active trials in "SC3 Research Group, Inc". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in SC3 Research Group, Inc, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in SC3 Research Group, Inc, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".